ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,751,504 | -40.2% | 5,284,386 | -6.3% | 0.01% | -39.1% |
| Q2 2023 | $28,014,329 | -1.7% | 5,636,686 | -2.3% | 0.02% | -8.0% |
| Q1 2023 | $28,498,791 | -8.4% | 5,768,986 | +16.7% | 0.02% | -10.7% |
| Q4 2022 | $31,097,232 | -41.2% | 4,943,916 | +1.0% | 0.03% | -45.1% |
| Q3 2022 | $52,843,000 | -5.1% | 4,892,866 | +0.2% | 0.05% | +2.0% |
| Q2 2022 | $55,666,000 | +24.5% | 4,882,966 | -0.5% | 0.05% | +47.1% |
| Q1 2022 | $44,696,000 | -35.7% | 4,906,266 | +5.2% | 0.03% | -29.2% |
| Q4 2021 | $69,554,000 | -24.9% | 4,661,815 | +29.3% | 0.05% | -26.2% |
| Q3 2021 | $92,631,000 | -0.7% | 3,604,300 | +0.8% | 0.06% | +3.2% |
| Q2 2021 | $93,289,000 | +102.4% | 3,577,030 | +174.0% | 0.06% | +96.9% |
| Q1 2021 | $46,081,000 | +47.4% | 1,305,400 | +5.4% | 0.03% | +39.1% |
| Q4 2020 | $31,257,000 | – | 1,238,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
| Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
| Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
| Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
| DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
| BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
| Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
| Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |